These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
421 related items for PubMed ID: 17303175
1. Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes. Watanabe K, Yamaori S, Funahashi T, Kimura T, Yamamoto I. Life Sci; 2007 Mar 20; 80(15):1415-9. PubMed ID: 17303175 [Abstract] [Full Text] [Related]
7. Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: role of phenolic hydroxyl groups in the resorcinol moiety. Yamaori S, Ebisawa J, Okushima Y, Yamamoto I, Watanabe K. Life Sci; 2011 Apr 11; 88(15-16):730-6. PubMed ID: 21356216 [Abstract] [Full Text] [Related]
9. Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions. Nasrin S, Watson CJW, Perez-Paramo YX, Lazarus P. Drug Metab Dispos; 2021 Dec 11; 49(12):1070-1080. PubMed ID: 34493602 [Abstract] [Full Text] [Related]
11. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes. Jiang R, Yamaori S, Takeda S, Yamamoto I, Watanabe K. Life Sci; 2011 Aug 01; 89(5-6):165-70. PubMed ID: 21704641 [Abstract] [Full Text] [Related]
12. Identification of the human cytochrome P450 enzymes involved in the in vitro biotransformation of lynestrenol and norethindrone. Korhonen T, Turpeinen M, Tolonen A, Laine K, Pelkonen O. J Steroid Biochem Mol Biol; 2008 May 01; 110(1-2):56-66. PubMed ID: 18356043 [Abstract] [Full Text] [Related]
13. Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes. Yamaori S, Kushihara M, Yamamoto I, Watanabe K. Biochem Pharmacol; 2010 Jun 01; 79(11):1691-8. PubMed ID: 20117100 [Abstract] [Full Text] [Related]
15. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450. Ghosal A, Satoh H, Thomas PE, Bush E, Moore D. Drug Metab Dispos; 1996 Sep 01; 24(9):940-7. PubMed ID: 8886602 [Abstract] [Full Text] [Related]
16. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes. Karam WG, Goldstein JA, Lasker JM, Ghanayem BI. Drug Metab Dispos; 1996 Oct 01; 24(10):1081-7. PubMed ID: 8894508 [Abstract] [Full Text] [Related]
17. Identification of CYP3A4 as the major enzyme responsible for 25-hydroxylation of 5beta-cholestane-3alpha,7alpha,12alpha-triol in human liver microsomes. Furster C, Wikvall K. Biochim Biophys Acta; 1999 Jan 29; 1437(1):46-52. PubMed ID: 9931427 [Abstract] [Full Text] [Related]
19. Confirmation that cytochrome P450 2C8 (CYP2C8) plays a minor role in (S)-(+)- and (R)-(-)-ibuprofen hydroxylation in vitro. Chang SY, Li W, Traeger SC, Wang B, Cui D, Zhang H, Wen B, Rodrigues AD. Drug Metab Dispos; 2008 Dec 29; 36(12):2513-22. PubMed ID: 18787056 [Abstract] [Full Text] [Related]
20. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations. Lasker JM, Wester MR, Aramsombatdee E, Raucy JL. Arch Biochem Biophys; 1998 May 01; 353(1):16-28. PubMed ID: 9578596 [Abstract] [Full Text] [Related] Page: [Next] [New Search]